Primerica’s second quarter was shaped by diverging trends across its core business lines, with management attributing ...

Greetings, and welcome to Primerica's Second Quarter 2025 Earnings webcast. [Operator Instructions] Please note that this ...

Jefferies analyst Suneet Kamath maintained a Hold rating on Primerica yesterday and set a price target of $283.00. The company’s shares closed yesterday at $258.27. Take advantage of TipRanks Premium ...

4 analysts have shared their evaluations of Primerica PRI during the recent three months, expressing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table ...

NYSE:PRI 1 Year Share Price vs Fair Value Explore Primerica's Fair Values from the Community and select yours ...

Primerica provides up to $5 million in coverage and allows coverage until age 95. Primerica also offers coverage without a medical exam, depending on the plan.

As regulators shift toward rewarding transparency, self-regulation and self-reporting, the way PFS Investments handled a longstanding problem serves as an example of how proactive remediation can turn ...

KBW analyst Ryan Krueger maintained a Hold rating on Primerica today and set a price target of $315.00. The company’s shares closed yesterday at $255.46. Elevate Your Investing ...

Financial services company Primerica (NYSE:PRI) reported Q2 CY2025 results , with sales up 7.1% year on year to $793.3 million. Its non-GAAP profit of $5.46 per share was 4.9% above analysts’ ...

Find the latest Primerica Common Sense Asset Builder VII (F00000V4JT.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Atezolizumab and bevacizumab enhance TACE effectiveness, significantly extending progression-free survival in unresectable ...